Study on the preparation of genipin crosslinked chitosan microspheres of resveratrol and in vitro release

被引:0
作者
Yue Zhang
Yi-feng Yu
Xian-xian Shi
Shu-chun Zhao
Ai-bing Chen
Dao-wei Huang
Dong-jie Niu
Zhen Qin
机构
[1] Hebei University of Science and Technology,School of Chemical and Pharmaceutical Engineering
[2] Hebei Research Center of Pharmaceutical and Chemical Engineering,undefined
[3] State Key Laboratory Breeding Base-Hebei Province Key Laboratory of Molecular Chemistry for Drug,undefined
来源
Journal of Polymer Research | 2013年 / 20卷
关键词
Resveratrol; Chitosan; Genipin; Microsphere; In vitro release;
D O I
暂无
中图分类号
学科分类号
摘要
Resveratrol has attracted considerable public and scientific attention because of its beneficial effects on human health. In this study, resveratrol was encapsulated into chitosan microspheres for improving the stability and evaluating the ability of controlled release. Chitosan microspheres were prepared by using an emulsification-crosslinking method, and specifically, a natural extraction genipin was used as crosslinking agent for pursuit better physiological compatibility. Factors which influence on the shape and dispersity of microspheres were investigated to optimize the preparing process of resveratrol loaded genipin-chitosanmicrospheres. The optimum condition was obtained and the prepared resveratrol loaded genipin-chitosanmicrospheres were characterized by many technical instruments. Entrapment efficiency of resveratrol in genipin-chitosanmicrospheres is up to 87.6 %, and loading capacity is 7.9 %. The in vitro release rate in pH 3.6 buffer solution reached to 33.8 % within 72 h, but was lower in pH 7.4 buffer solution.
引用
收藏
相关论文
共 111 条
[1]  
Robards K(2003)undefined J Chromatogr A 1000 657-691
[2]  
Lucio M(2006)undefined J Chromatogr A 1114 263-268
[3]  
Roberto MP(2005)undefined J Clin Nutr 81 230S-242S
[4]  
Tesei I(2000)undefined Life Sci 66 663-673
[5]  
Claudine M(2001)undefined Carcinogenesis 22 1111-1117
[6]  
Gary W(2009)undefined J Chromatogr A 1216 281-287
[7]  
Christine M(2012)undefined Pharmacol Res 65 584-591
[8]  
Frémont L(1992)undefined Am J Enol Vitic 43 49-52
[9]  
Gusman J(1997)undefined Clin Biochem 30 91-113
[10]  
Malonne H(2000)undefined Anal Chim Acta 424 19-25